Sonali Sinha

Sonali Sinha

Auto-generated profile, based on publicly available information

Sonali Sinha

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
MGManosij Ghosh
Manosij Ghosh
MJManivannan J
Manivannan J
SSSonali Sinha
Sonali Sinha
ACAnirban Chakraborty
Anirban Chakraborty
SMSanjaya Kumar Mallick
Sanjaya Kumar Mallick
AMAnita Mukherjee
Anita Mukherjee

1 February 2013 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
MJManivannan J
Manivannan J
SSSonali Sinha
Sonali Sinha
MGManosij Ghosh
Manosij Ghosh
AMAnita Mukherjee
Anita Mukherjee

1 October 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SSSonali Sinha
Sonali Sinha
DBDhrubojyoti Biswas
Dhrubojyoti Biswas
AMAnita Mukherjee
Anita Mukherjee

1 September 1995 in Physical Review B
Verified
Journal Article
Closed access
PDF file
WDW. Dmowski
W. Dmowski
RMR. J. McQueeney
R. J. McQueeney
Takeshi EgamiTakeshi Egami
Takeshi Egami
YFY. P. Feng
Y. P. Feng
SSS. K. Sinha
S. K. Sinha
SUS. Uchida
S. Uchida
X-ray diffuse scattering from single crystals of La2−x Srx CuO4 (x=0.10,0.15,0.20) was studied in the vicinity of several Bragg peaks near the c* axis as a function of temperature. While the diffuse scattering at room temperature is dominated by phonon scattering, at low temperatures residual nonphonon diffuse scattering is clearly seen. The intensity of the residual nonphonon scattering depends upon temperature and composition in a characteristic manner. It is suggested that the nonphonon scattering is due to local lattice distortions induced by charge carriers in these compounds.

9 July 2024 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
VNVictor Ng
Victor Ng
SSSonali Sinha
Sonali Sinha
ANArdijana Novaj
Ardijana Novaj
JMJennifer Ma
Jennifer Ma
NMNiamh McDermott
Niamh McDermott
NRNadeem Riaz
Nadeem Riaz
Purpose: The importance of the DNA damage response in mediating effects of radiotherapy (RT) has galvanized efforts to target this pathway with radiosensitizers. Yet early clinical trials of this approach have failed to yield a benefit in unselected populations. We hypothesized that ataxia–telangiectasia mutated (Atm)–null tumors would demonstrate genotype-specific synergy between RT and an inhibitor of the DNA damage response protein ataxia–telangiectasia and Rad3-related (ATR) kinase. Experimental Design: We investigated the synergistic potential of the ATR inhibitor (ATRi) RP-3500 and RT in two Atm-null and isogenic murine models, both in vitro and in vivo. Staining of γ-H2AX foci, characterization of the immune response via flow cytometry, and tumor rechallenge experiments were performed to elucidate the mechanism of interaction. To examine genotype specificity, we tested the interaction of ATRi and RT in a Brca1-null model. Finally, patients with advanced cancer with ATM alterations were enrolled in a phase I/II clinical trial to validate preclinical findings. Results: Synergy between RP-3500 and RT was confirmed in Atm-null lines in vitro, characterized by an accumulation of DNA double-strand breaks. In vivo, Atm-null tumor models had higher rates of durable control with RT and ATRi than controls. In contrast, there was no synergy in tumors lacking Brca1. Analysis of the immunologic response indicated that efficacy is largely mediated by cell-intrinsic mechanisms. Lastly, early results from our clinical trial showed complete responses in patients. Conclusions: Genotype-directed radiosensitization with ATRi and RT can unleash significant therapeutic benefit and could represent a novel approach to develop more effective combinatorial synthetic cytotoxic RT-based treatments. See related commentary by Schrank and Colbert, p. 5505

1 August 2010 in The Nucleus
Verified
Journal Article
Closed access
PDF file
MGManosij Ghosh
Manosij Ghosh
JPJit Paul
Jit Paul
SSSonali Sinha
Sonali Sinha
AMAnita Mukherjee
Anita Mukherjee